COVID – 19 Dashboard
Dr. Mathew George Publishes High-Impact Article in Prestigious Journal
Notice of E-Grants Scholarship for Higher Education
Applications Invited for ‘Heartian Guru Shreshta’ Awards 2024–25
Rajdeep Sardesai to Receive Chavara Media Award 2024
23rd Prof. K. V. Thomas Endowment National Seminar on Frontiers in Materials Science
Globally, as of 29 November 2020, there have been 61,869,330 confirmed cases of COVID-19, including 1,448,896 deaths, reported to WHO.
COVID – 19 in India
Active – 446952
Deaths – 137139 (1.45%)
COVID – 19 in Kerala
Active – 64589
Deaths – 2223 (0.37%)
COVID-19 vaccine
Researchers worldwide are working around the clock to find a vaccine against SARS-CoV-2, the virus causing the COVID-19 pandemic. The Herculean effort means that a fast-tracked vaccine could come to market anywhere from the end of 2020 to the middle of 2021.
To date, just two coronavirus vaccine has been approved. Sputnik V – formerly known as Gam-COVID-Vac and developed by the Gamaleya Research Institute in Moscow – was approved by the Ministry of Health of the Russian Federation on 11 August. Experts have raised considerable concern about the vaccine’s safety and efficacy given it has not yet entered Phase 3 clinical trials. A second vaccine in Russia, EpiVacCorona, has also been granted regulatory approval, also without entering Phase 3 clinical trials.
